Amylyx Pharmaceuticals Inc (AMLX)
| Sector: | Health Care |
| Super Investor Stats: | |
| Ownership count: | 0 |
| Ownership rank: | -- |
| % of all portfolios: | 0% |
| |
| Total insider Buys/Sells last 6 months: |
| Transactions | Total |
| Buys |
1 |
$37,005 |
| Sells |
15 |
$494,469 |
|
Portfolio Manager |
% of portfolio |
Recent activity |
Shares |
Value |
Open Market Insider Buys
| Date Filed |
Reporting Name |
Relationship |
Trans. Date |
Shares |
Price $ |
Total Value $ |
| 24 Mar 2025 |
ZEIHER BERNHARDT G |
Director |
20 Mar 2025 |
10,000 |
3.70 |
37,005 |
| 16 Sep 2024 |
FRATES JAMES M |
Chief Financial Officer |
12 Sep 2024 |
40,000 |
2.53 |
101,368 |
| 09 Sep 2024 |
FIRESTONE KAREN |
Director |
05 Sep 2024 |
50,000 |
2.13 |
106,590 |
| 05 Sep 2024 |
MILNE GEORGE M JR |
Director |
03 Sep 2024 |
100,000 |
2.20 |
219,800 |
| 16 May 2024 |
QUIMI DAPHNE |
Director |
15 May 2024 |
2,250 |
1.89 |
4,252 |
| 16 May 2024 |
QUIMI DAPHNE |
Director |
14 May 2024 |
2,750 |
1.88 |
5,184 |
| 19 Dec 2023 |
FIRESTONE KAREN |
Director |
15 Dec 2023 |
4,000 |
14.97 |
59,880 |
| 20 Mar 2023 |
FIRESTONE KAREN |
Director |
16 Mar 2023 |
1,000 |
31.99 |
31,990 |
* "Hold Price" is the last known price at which an investor still held a security. It is the closing price of the security as of the portfolio date (quarter end). This value is only provided when a security is owned by at least two investors. In the case of reporting dates being different, a weighted average price is calculated.
P = Preferred Stock